Transcription factors and drug resistance

Kimitoshi Kohno, Takeshi Uchiumi, Ichiro Niina, Tetsuro Wakasugi, Tomonori Igarashi, Yasutomo Momii, Takeshi Yoshida, Ken Ichi Matsuo, Naoya Miyamoto, Hiroto Izumi

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Intrinsic or acquired resistance to anticancer agents is a major obstacle to the success of chemotherapy. Anticancer agents are known to modulate signal transduction pathways and alter expression of genes that play an important role in drug resistance. Emerging evidence suggests that the complexity of genomic response against anticancer agents arise from elaborate gene expression by multiple transcription factors. Here, we briefly describe the development of solid tumours and the appearance of drug-resistant cells. We also review what is known of the transcription factors that are involved in resistance to drugs, particularly cisplatin.

Original languageEnglish
Pages (from-to)2577-2586
Number of pages10
JournalEuropean Journal of Cancer
Volume41
Issue number16
DOIs
Publication statusPublished - Jan 1 2005
Externally publishedYes

Fingerprint

Drug Resistance
Antineoplastic Agents
Transcription Factors
Gene Expression
Cisplatin
Signal Transduction
Drug Therapy
Pharmaceutical Preparations
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Kohno, K., Uchiumi, T., Niina, I., Wakasugi, T., Igarashi, T., Momii, Y., ... Izumi, H. (2005). Transcription factors and drug resistance. European Journal of Cancer, 41(16), 2577-2586. https://doi.org/10.1016/j.ejca.2005.08.007

Transcription factors and drug resistance. / Kohno, Kimitoshi; Uchiumi, Takeshi; Niina, Ichiro; Wakasugi, Tetsuro; Igarashi, Tomonori; Momii, Yasutomo; Yoshida, Takeshi; Matsuo, Ken Ichi; Miyamoto, Naoya; Izumi, Hiroto.

In: European Journal of Cancer, Vol. 41, No. 16, 01.01.2005, p. 2577-2586.

Research output: Contribution to journalArticle

Kohno, K, Uchiumi, T, Niina, I, Wakasugi, T, Igarashi, T, Momii, Y, Yoshida, T, Matsuo, KI, Miyamoto, N & Izumi, H 2005, 'Transcription factors and drug resistance', European Journal of Cancer, vol. 41, no. 16, pp. 2577-2586. https://doi.org/10.1016/j.ejca.2005.08.007
Kohno K, Uchiumi T, Niina I, Wakasugi T, Igarashi T, Momii Y et al. Transcription factors and drug resistance. European Journal of Cancer. 2005 Jan 1;41(16):2577-2586. https://doi.org/10.1016/j.ejca.2005.08.007
Kohno, Kimitoshi ; Uchiumi, Takeshi ; Niina, Ichiro ; Wakasugi, Tetsuro ; Igarashi, Tomonori ; Momii, Yasutomo ; Yoshida, Takeshi ; Matsuo, Ken Ichi ; Miyamoto, Naoya ; Izumi, Hiroto. / Transcription factors and drug resistance. In: European Journal of Cancer. 2005 ; Vol. 41, No. 16. pp. 2577-2586.
@article{c36e99df1d814d58ba8fd97337b381f5,
title = "Transcription factors and drug resistance",
abstract = "Intrinsic or acquired resistance to anticancer agents is a major obstacle to the success of chemotherapy. Anticancer agents are known to modulate signal transduction pathways and alter expression of genes that play an important role in drug resistance. Emerging evidence suggests that the complexity of genomic response against anticancer agents arise from elaborate gene expression by multiple transcription factors. Here, we briefly describe the development of solid tumours and the appearance of drug-resistant cells. We also review what is known of the transcription factors that are involved in resistance to drugs, particularly cisplatin.",
author = "Kimitoshi Kohno and Takeshi Uchiumi and Ichiro Niina and Tetsuro Wakasugi and Tomonori Igarashi and Yasutomo Momii and Takeshi Yoshida and Matsuo, {Ken Ichi} and Naoya Miyamoto and Hiroto Izumi",
year = "2005",
month = "1",
day = "1",
doi = "10.1016/j.ejca.2005.08.007",
language = "English",
volume = "41",
pages = "2577--2586",
journal = "European Journal of Cancer and Clinical Oncology",
issn = "0959-8049",
publisher = "Elsevier Limited",
number = "16",

}

TY - JOUR

T1 - Transcription factors and drug resistance

AU - Kohno, Kimitoshi

AU - Uchiumi, Takeshi

AU - Niina, Ichiro

AU - Wakasugi, Tetsuro

AU - Igarashi, Tomonori

AU - Momii, Yasutomo

AU - Yoshida, Takeshi

AU - Matsuo, Ken Ichi

AU - Miyamoto, Naoya

AU - Izumi, Hiroto

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Intrinsic or acquired resistance to anticancer agents is a major obstacle to the success of chemotherapy. Anticancer agents are known to modulate signal transduction pathways and alter expression of genes that play an important role in drug resistance. Emerging evidence suggests that the complexity of genomic response against anticancer agents arise from elaborate gene expression by multiple transcription factors. Here, we briefly describe the development of solid tumours and the appearance of drug-resistant cells. We also review what is known of the transcription factors that are involved in resistance to drugs, particularly cisplatin.

AB - Intrinsic or acquired resistance to anticancer agents is a major obstacle to the success of chemotherapy. Anticancer agents are known to modulate signal transduction pathways and alter expression of genes that play an important role in drug resistance. Emerging evidence suggests that the complexity of genomic response against anticancer agents arise from elaborate gene expression by multiple transcription factors. Here, we briefly describe the development of solid tumours and the appearance of drug-resistant cells. We also review what is known of the transcription factors that are involved in resistance to drugs, particularly cisplatin.

UR - http://www.scopus.com/inward/record.url?scp=27544467567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27544467567&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2005.08.007

DO - 10.1016/j.ejca.2005.08.007

M3 - Article

VL - 41

SP - 2577

EP - 2586

JO - European Journal of Cancer and Clinical Oncology

JF - European Journal of Cancer and Clinical Oncology

SN - 0959-8049

IS - 16

ER -